Patients with type 2 diabetes mellitus receiving routine clinical care, focusing on issues of glycemic control and the use of the triglyceride glucose (TyG) index as an alternative method to estimate HbA1c. Triglycerides, Blood Glucose, Glycated Hemoglobin A, Type 2 Diabetes Mellitus, Primary Health Care
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with a diagnosis of type 2 diabetes mellitus. 2.Aged 20 years or older. 3.Having laboratory results for triglyceride, fasting blood sugar (FBS), and HbA1c obtained on the same day during the year 2023 at Lampang Hospital.
Exclusion criteria
Exclusion criteria: 1.Patients with incomplete laboratory or clinical data. 2.Patients who were not in a fasting state for triglyceride or glucose testing. 3.Patients diagnosed with type 1 diabetes. 4.Patients with missing HbA1c results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemoglobin A1c At the date when triglyceride, fasting blood glucose, and HbA1c were measured on the same visit during the year 2023. Laboratory measurement of HbA1c using standard clinical chemistry analyzers at Lampang Hospital. | — |
Secondary
| Measure | Time frame |
|---|---|
| Model Calibration At baseline Calibration plot assessment | — |
Countries
Thailand
Contacts
Lampang Hospital